美迪善® 25 年历程中的发展、挑战与解决方案及其对盘尾丝虫病防治的影响 - Suppr

Suppr

超能文献

Growth, Challenges, and Solutions over 25 Years of Mectizan and the Impact on Onchocerciasis Control.

作者信息

Lawrence Joni, Sodahlon Yao K, Ogoussan Kisito T, Hopkins Adrian D

机构信息

Mectizan Donation Program, Decatur, Georgia, United States of America.

出版信息

PLoS Negl Trop Dis. 2015 May 14;9(5):e0003507. doi: 10.1371/journal.pntd.0003507. eCollection 2015 May.

DOI:10.1371/journal.pntd.0003507

PMID:25974081

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4431881/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b438/4431881/a6420a2d7187/pntd.0003507.g001.jpg

相似文献

Growth, Challenges, and Solutions over 25 Years of Mectizan and the Impact on Onchocerciasis Control.美迪善® 25 年历程中的发展、挑战与解决方案及其对盘尾丝虫病防治的影响

PLoS Negl Trop Dis. 2015 May 14;9(5):e0003507. doi: 10.1371/journal.pntd.0003507. eCollection 2015 May.

The Mectizan Donation Program (MDP).美迪善捐赠计划（MDP）。

Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:39-44. doi: 10.1179/136485908X337481.

DISTRIBUTION AND UTILISATION OF IVERMECTIN (MECTIZAN): A CHEMOTHERAPEUTIC APPROACH TO THE CONTROL OF ONCHOCERCIASIS IN OLD OHAOZARA LGA, EBONYI STATE, EASTERN NIGERIA.

J Egypt Soc Parasitol. 2015 Dec;45(3):663-70.

Special intervention zones.特别干预区

Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:23-4. doi: 10.1179/136485908X337445.

The Mectizan Donation Program: 20 years of successful collaboration - a retrospective.美迪善捐赠计划：20年成功合作回顾

Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:7-11. doi: 10.1179/136485908X337418.

Mectizan(®) procurement and delivery for onchocerciasis mass drug administration programmes.梅克丁（®）采购和交付用于盘尾丝虫病大规模药物治疗方案。

Acta Trop. 2011 Sep;120 Suppl 1:S173-6. doi: 10.1016/j.actatropica.2010.10.004. Epub 2010 Oct 23.

Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.美迪善捐赠计划20年控制盘尾丝虫病的操作经验教训。

Trop Med Int Health. 2008 May;13(5):689-96. doi: 10.1111/j.1365-3156.2008.02049.x.

The World Bank.世界银行

Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:31-3. doi: 10.1179/136485908X337463.

A multi-centre study of the effect of Mectizan treatment on onchocercal skin disease: clinical findings.美迪善治疗盘尾丝虫性皮肤病效果的多中心研究：临床研究结果

Ann Trop Med Parasitol. 1998 Apr;92 Suppl 1:S139-45.

Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.消除人体盘尾丝虫病：伊维菌素（美索巴莫）单药疗法取得进展的历史和当前可行性。

Acta Trop. 2011 Sep;120 Suppl 1:S100-8. doi: 10.1016/j.actatropica.2010.08.009. Epub 2010 Aug 27.

引用本文的文献

Mapping the Burden of Visual Impairment Due to Onchocerciasis Infection in Central Africa from 1990 to 2019.绘制1990年至2019年中非因盘尾丝虫病感染导致的视力损害负担情况。

Clin Ophthalmol. 2023 Nov 6;17:3373-3377. doi: 10.2147/OPTH.S431911. eCollection 2023.

Status of Onchocerciasis Elimination in Gabon and Challenges: A Systematic Review.加蓬盘尾丝虫病消除现状与挑战：一项系统评价

Microorganisms. 2023 Jul 29;11(8):1946. doi: 10.3390/microorganisms11081946.

Effects of larval exposure to sublethal doses of ivermectin on adult fitness and susceptibility to ivermectin in Anopheles gambiae s.s.伊维菌素亚致死剂量对冈比亚按蚊成蚊适合度和伊维菌素敏感性的影响

Parasit Vectors. 2023 Aug 21;16(1):293. doi: 10.1186/s13071-023-05888-w.

Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes.伊维菌素代谢物的药代动力学及其对致倦库蚊的活性。

Malar J. 2023 Jun 24;22(1):194. doi: 10.1186/s12936-023-04624-0.

Survival of worm masses of Onchocerca ochengi in gerbils and hamsters: implications for the development of an in vivo macrofilaricide screening model.奥氏曼森线虫虫体在沙鼠和仓鼠体内的存活情况：对体内大丝虫筛选模型开发的影响。

Parasitol Res. 2023 Jul;122(7):1581-1591. doi: 10.1007/s00436-023-07859-7. Epub 2023 May 8.

The prevalence of onchocerciasis in Africa and Yemen, 2000-2018: a geospatial analysis.2000-2018 年非洲和也门盘尾丝虫病的流行情况：一项地理空间分析。

BMC Med. 2022 Sep 7;20(1):293. doi: 10.1186/s12916-022-02486-y.

Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside.治疗盘尾丝虫病的药物研发：依美硝唑的群体药代动力学和不良事件建模。

PLoS Negl Trop Dis. 2022 Mar 10;16(3):e0010219. doi: 10.1371/journal.pntd.0010219. eCollection 2022 Mar.

Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning.预测非洲盘尾丝虫病的环境适宜性，以辅助制定消除规划。

PLoS Negl Trop Dis. 2021 Jul 28;15(7):e0008824. doi: 10.1371/journal.pntd.0008824. eCollection 2021 Jul.

Building country capacity to sustain NTD programs and progress: A call to action.建设国家维持被忽视热带病防治项目及推动进展的能力：行动呼吁。

PLoS Negl Trop Dis. 2020 Oct 8;14(10):e0008565. doi: 10.1371/journal.pntd.0008565. eCollection 2020 Oct.

Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study).一项关于伊维菌素单剂量与双剂量用于控制疥疮的大规模药物管理策略的非劣效性随机对照试验方案（RISE 研究）。

BMJ Open. 2020 Aug 30;10(8):e037305. doi: 10.1136/bmjopen-2020-037305.

本文引用的文献

African Programme for Onchocerciasis Control: meeting of National Onchocerciasis Task Forces, September 2012.非洲盘尾丝虫病控制计划：国家盘尾丝虫病特别工作组会议，2012年9月

Wkly Epidemiol Rec. 2012 Dec 7;87(49/50):494-502.

Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.在非洲流行区使用伊维菌素治疗消灭盘尾丝虫病的原理验证：马里和塞内加尔研究的最终结果。

PLoS Negl Trop Dis. 2012;6(9):e1825. doi: 10.1371/journal.pntd.0001825. Epub 2012 Sep 13.

Progress towards eliminating onchocerciasis in the WHO Region of the Americas in 2011: interruption of transmission in Guatemala and Mexico.2011年美洲世卫组织区域在消除盘尾丝虫病方面取得的进展：危地马拉和墨西哥传播的中断。

Wkly Epidemiol Rec. 2012 Aug 17;87(33):309-14.

A research agenda for helminth diseases of humans: intervention for control and elimination.人类寄生虫病研究议程：干预以控制和消除寄生虫病。

PLoS Negl Trop Dis. 2012;6(4):e1549. doi: 10.1371/journal.pntd.0001549. Epub 2012 Apr 24.

A research agenda for helminth diseases of humans: towards control and elimination.人类蠕虫病研究议程：迈向控制和消除。

PLoS Negl Trop Dis. 2012;6(4):e1547. doi: 10.1371/journal.pntd.0001547. Epub 2012 Apr 24.

Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.在非洲流行区使用伊维菌素治疗消灭盘尾丝虫病的可行性：来自马里和塞内加尔研究的初步证据。

PLoS Negl Trop Dis. 2009 Jul 21;3(7):e497. doi: 10.1371/journal.pntd.0000497.

Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.美迪善捐赠计划20年控制盘尾丝虫病的操作经验教训。

Trop Med Int Health. 2008 May;13(5):689-96. doi: 10.1111/j.1365-3156.2008.02049.x.

Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp.伊维菌素治疗感染罗阿丝虫和疟原虫属的患者后出现的脑病

Am J Trop Med Hyg. 2008 Apr;78(4):546-51.

A Framework for Decision-Making for Mass Distribution of Mectizan(R) in Areas Endemic for Loa loa.在罗阿丝虫病流行地区大规模分发美迪善（Mectizan®）的决策框架

Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S9. doi: 10.1186/1475-2883-2-S1-S9.

APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. African Programme for Onchocerciasis Control.消灭盘尾丝虫病非洲方案的伊维菌素社区导向治疗（CDTI）策略及其为最贫困人群提供额外卫生服务的潜力。

Ann Trop Med Parasitol. 2002 Mar;96 Suppl 1:S93-104. doi: 10.1179/000349802125000673.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验